Cell
Volume 146, Issue 2, 22 July 2011, Pages 318-331
Journal home page for Cell

Resource
Generation of Isogenic Pluripotent Stem Cells Differing Exclusively at Two Early Onset Parkinson Point Mutations

https://doi.org/10.1016/j.cell.2011.06.019Get rights and content
Under an Elsevier user license
open archive

Summary

Patient-specific induced pluripotent stem cells (iPSCs) derived from somatic cells provide a unique tool for the study of human disease, as well as a promising source for cell replacement therapies. One crucial limitation has been the inability to perform experiments under genetically defined conditions. This is particularly relevant for late age onset disorders in which in vitro phenotypes are predicted to be subtle and susceptible to significant effects of genetic background variations. By combining zinc finger nuclease (ZFN)-mediated genome editing and iPSC technology, we provide a generally applicable solution to this problem, generating sets of isogenic disease and control human pluripotent stem cells that differ exclusively at either of two susceptibility variants for Parkinson's disease by modifying the underlying point mutations in the α-synuclein gene. The robust capability to genetically correct disease-causing point mutations in patient-derived hiPSCs represents significant progress for basic biomedical research and an advance toward hiPSC-based cell replacement therapies.

Highlights

► General approach to generate isogenic disease and control pluripotent stem cells ► ZFNs-mediated genome editing of human pluripotent stem cells without drug selection ► Generation of isogenic cells differing at two PD-causing mutations in α-synuclein ► Correction of PD-causing A53T mutation in patient-derived hiPSCs

Cited by (0)